| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 431.59B | 404.01B | 370.14B | 339.90B | 317.60B | 308.43B |
| Gross Profit | 115.08B | 105.83B | 97.17B | 89.35B | 83.14B | 79.22B |
| EBITDA | 62.89B | 56.36B | 51.67B | 45.62B | 43.36B | 42.77B |
| Net Income | 31.75B | 26.97B | 25.25B | 20.20B | 20.49B | 16.64B |
Balance Sheet | ||||||
| Total Assets | 319.53B | 330.88B | 314.22B | 280.40B | 268.65B | 254.03B |
| Cash, Cash Equivalents and Short-Term Investments | 50.78B | 64.80B | 59.26B | 43.65B | 48.70B | 46.28B |
| Total Debt | 42.66B | 42.60B | 35.54B | 38.00B | 41.85B | 47.44B |
| Total Liabilities | 146.95B | 159.57B | 145.90B | 138.80B | 137.97B | 140.04B |
| Stockholders Equity | 170.46B | 169.05B | 166.42B | 139.89B | 128.92B | 112.27B |
Cash Flow | ||||||
| Free Cash Flow | 59.83B | 41.83B | 39.52B | 25.69B | 27.81B | 37.74B |
| Operating Cash Flow | 64.06B | 44.92B | 41.69B | 28.42B | 29.43B | 40.57B |
| Investing Cash Flow | -17.82B | -8.93B | -8.55B | -15.54B | -10.96B | -11.58B |
| Financing Cash Flow | -31.30B | -30.61B | -17.62B | -18.04B | -16.12B | -16.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥145.02B | 9.34 | 11.52% | 2.76% | 4.00% | 38.72% | |
67 Neutral | ¥418.84B | 18.98 | ― | 2.17% | 10.42% | 28.75% | |
66 Neutral | ¥167.06B | 15.99 | 18.89% | 2.78% | 11.90% | 60.66% | |
65 Neutral | ¥30.51B | 10.75 | 10.34% | 4.82% | -3.03% | 38.83% | |
64 Neutral | ¥771.60B | 20.55 | ― | 1.39% | 4.95% | 9.54% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | ¥667.56B | 22.20 | 10.07% | 1.76% | 11.66% | -0.21% |